HomeCompareVNTA vs PLD

VNTA vs PLD: Dividend Comparison 2026

VNTA yields 4987.53% · PLD yields 3.18%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VNTA wins by $60726414423796.08M in total portfolio value
10 years
VNTA
VNTA
● Live price
4987.53%
Share price
$0.04
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$60726414423802.59M
Annual income
$58,422,163,401,288,310,000.00
Full VNTA calculator →
PLD
PLD
● Live price
3.18%
Share price
$128.78
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6.50M
Annual income
$5,256,436.18
Full PLD calculator →

Portfolio growth — VNTA vs PLD

📍 VNTA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVNTAPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VNTA + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
VNTA pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VNTA
Annual income on $10K today (after 15% tax)
$423,940.15/yr
After 10yr DRIP, annual income (after tax)
$49,658,838,891,095,065,000.00/yr
PLD
Annual income on $10K today (after 15% tax)
$270.62/yr
After 10yr DRIP, annual income (after tax)
$4,467,970.75/yr
At 15% tax rate, VNTA beats the other by $49,658,838,891,090,600,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VNTA + PLD for your $10,000?

VNTA: 50%PLD: 50%
100% PLD50/50100% VNTA
Portfolio after 10yr
$30363207211904.54M
Annual income
$29,211,081,700,646,785,000.00/yr
Blended yield
96.21%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

VNTA
No analyst data
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+5.6% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VNTA buys
0
PLD buys
0
No recent congressional trades found for VNTA or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVNTAPLD
Forward yield4987.53%3.18%
Annual dividend / share$2.00$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4%
Portfolio after 10y$60726414423802.59M$6.50M
Annual income after 10y$58,422,163,401,288,310,000.00$5,256,436.18
Total dividends collected$60570499970588.68M$6.37M
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: VNTA vs PLD ($10,000, DRIP)

YearVNTA PortfolioVNTA Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$509,453$498,753.12$11,255$555.24+$498.2KVNTA
2$24,291,968$23,746,853.30$13,062$1,018.59+$24.28MVNTA
3$1,084,224,114$1,058,231,708.37$15,903$1,926.67+$1084.21MVNTA
4$45,302,256,588$44,142,136,785.73$20,839$3,823.32+$45302.24MVNTA
5$1,772,207,810,855$1,723,734,396,305.83$30,464$8,166.08+$1772207.78MVNTA
6$64,916,695,091,411$63,020,432,733,796.11$52,054$19,457.30+$64916695.04MVNTA
7$2,226,904,004,397,647$2,157,443,140,649,837.00$109,886$54,188.93+$2226904004.29MVNTA
8$71,550,063,790,460,920$69,167,276,505,755,440.00$304,030$186,451.18+$71550063790.16MVNTA
9$2,153,505,628,518,013,700$2,076,947,060,262,220,500.00$1,166,125$840,813.32+$2153505628516.85MVNTA
10$60,726,414,423,802,585,000$58,422,163,401,288,310,000.00$6,504,190$5,256,436.18+$60726414423796.08MVNTA

VNTA vs PLD: Complete Analysis 2026

VNTAStock

Ventana Biotech, Inc., a development stage biotech company, identifies, evaluates, acquires, develops, and partners commercialization of intellectual property in the area of drug candidates for personalized medicine. The company focuses in the areas of anti-obesity and related illnesses. The company holds rights for the formula for a medicament containing chewing gum with a composition of the extract of hoodia gordonii and 2-hydroxyoleic acid for the treatment of obesity, hypertension, and other metabolic disorders. The company develops appetite suppressant chewing gums, including the low dosage product for the over-the-counter market and the high dosage product for distribution by pharmacists. It intends to market low dosage product though drug and health food stores. The company was formerly known as Personalica, Inc. and changed its name to Ventana Biotech, Inc. in October 2008. Ventana Biotech, Inc. was founded in 1989 and is based in Butschwil, Switzerland.

Full VNTA Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this VNTA vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VNTA vs SCHDVNTA vs JEPIVNTA vs OVNTA vs KOVNTA vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.